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RATIONALE: HDR are frequent motives for consultation in Allergology
services. Possible etiologic factors and clinical presentation differences
between Latin American children and adults have not been described yet.
METHODS: An observational cross sectional study using a modified
ENDA questionnaire was implemented in 19 allergology units in 11 Latin-
American countries, reporting patients presenting HDR in the last year
before consultation. Causal relationship was categorized according to
WHO-UMC Causality Categories: certain, probable, possible, unlikely
and conditional.
RESULTS: 727 patients, 144 (19.8%) of them under 18 years old,
presented 732 reactions. Female gender was 71.7% in adults, and 50% in
children. Atopic history was present in 44.9 and 63.8% and a history of
previous drug reaction in 31.9 and 36.9% of adults and children,
respectively. Fourteen percent of adult, and 10.7% of children had
presented previous reactions with the same drug. The clinical picture of
the reaction in adults and children was angioedema in 47.9 and 48.6%,
urticaria in 44.5 and 41.8%,maculopapular andmacular exanthema in 20.3
and 22.6 %, erythema multiforme and SJS in 3.6 and 2.7% respectively.
Certain and probable causal relationships were attributed in adults and
children to NSAIDs in 55.7 and 60.3 %, beta lactams in 11.2 and 19.8%,
non beta lactam antibiotics in 8.4 and 2.5 %, anticonvulsants in 3.2 and
1.7%, chemotherapy 0.8 and 2.5% of patients, respectively.
CONCLUSIONS: Female sex was predominant in adults but not in
children. NSAIDs and antibiotics were the drugs implicated in more than
75% of patients. Beta lactam antibiotics were more frequently involved in
children.
911 Copy Number Variations In ALOX5 and PTGER1 Genes AreAssociated With Susceptibility To AERD and Mnsaid-UA
Mrs. Maria Del Carmen Plaza Seron, Bsc1, Dr. Pedro Ayuso
Parejo, PhD1, Dr. Natalia Blanca-Lopez, MD, PhD1, Dr. Inmaculada
Do~na, MD, PhD2, Dr. Jose A. Cornejo-Garcia, PhD3, Dr. Marıa Jose
Torres, MD, PhD2, Dr. Javier Fernandez4, Dr. Jose Julio Laguna, MD,
PhD5, Veronique Godineau3, Ms. Miriam Osorio6, Mrs. Luisa
Galindo, RN2, Dr. Gabriela Canto, MD, PhD1, Dr. Miguel Blanca, MD,
PhD2; 1Allergy Service, Infanta Leonor Hospital, Madrid, Spain, 2Allergy
Service, Carlos Haya Hospital, Malaga, Spain, 3Research Laboratory, Car-
los Haya Hospital, Malaga, Spain, 4UMHAlicante G.University Hospital -
Allergy Sect., Alicante, Spain, 5De La Cruz Roja Hospital, Madrid, Spain,
6Research Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, Spain.
RATIONALE: Aspirin-exacerbated respiratory disease (AERD) and
Multiple NSAID–triggered urticaria and/or angioedema and anaphylaxis
in patients without pre-existing chronic urticaria (MNSAID-UA) are the
main manifestations of hypersensitivity reactions. Both are mediated by a
non-specific immunological mechanism based on NSAIDs capacity to
inhibit COX-1 and evoke an unbalance of metabolic pathway ofarachidonic acid. Copy number variations (CNVs) are DNA segments
present at variable copy number thatmay affect the expression of genes and
be associated with susceptibility to diseases. The aim of this study was to
analyze association of CNV in genes implicated in arachidonic acid
pathway with MNSAID-UA and AERD.
METHODS: We studied a total of 150 patients with AERD, 310
MNSAID-UA and 315 tolerant controls. We used TaqMan copy number
assays to analyze CNVs inPTGS1, PTGS2, LTC4S, ALOX5 andPTGER1-4
genes. The results were analyzed using the CopyCaller Software and SPSS
11.5 program.
RESULTS: We found differences in ALOX5 and PTGER1 genes. All con-
trols showed 2 copies of each gene analyzed. Concerning to ALOX5, we
identified 7 AERD patients (5.0%; AERD vs. Controls P< 0.001) and 13
MNSAIDS-UA patients (4.17%; MNSAID-UA vs. Controls P< 0.001)
with a single copy of this gene. Regarding to PTGER1, we identified 19
MNSAID-UA patients (6.11%; MNSAID-UA vs. Controls P< 0.0001)
with a single copy of the gene, no AERD patients showed a single copy.
CONCLUSIONS: We found statistically significant differences in CNVs
of genes ALOX5 and PTGER1 between healthy controls andMNSAID-UA
and AERD. Whether these variations imply a dysfunctional gene expres-
sion require further studies.
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RATIONALE: Non-steroid anti-inflammatory drugs (NSAIDs) are the
compounds more frequently involved in hypersensitivity drugs reactions.
Multiple NSAID–triggered urticaria and/or angioedema and anaphylaxis
in patients without pre-existing chronic urticaria (MNSAID-UA) are
considered the most frequent entities. The underlying mechanism pro-
posed is based on the pharmacological properties of the NSAIDs. These
reactions occur as a result of mast cell activation and subsequent
degranulation and generation of lipid-derived mediators. These cells can
be activated by IgE-dependent and IgE-independent mechanisms that
share common signaling pathways. In this work, we aimed to analyze the
association between single nucleotide polymorphisms (SNPs) in key genes
involved in mast cell activation and MNSAID-UA.
METHODS: A total of 450 patients with MNSAID-UA and 500
individuals who tolerated NSAIDs were included. Nine SNPs in 5 genes
(rs290986 in SYK, rs7140 in LAT1, rs2228246 and rs753381 in PLCG1,
rs2307198, rs12749354 and rs12746200 in PLA2G4A; and rs35211496
and rs1805034 in TNFRSF11A genes) were genotyped using TaqMan
probes.
RESULTS: MNSAID-UA patients were subdivided according to the type
of response and significant differences were found between MNSAID-UA
patients who only developed urticaria and the following SNPs: rs2228246,
OR50.30 (95% CI 50.11-0.82; P50.031) rs35211496, OR52.67 (95%
CI51.37-5.19; P50.0024) and rs12746200, OR50.14 (95% CI50.03-
0.59; P50.019). Nevertheless, statistically significant differences were
not found in genotype frequencies of these SNPs between MNSAID-UA
and tolerant.
CONCLUSIONS: We found an association between non synonymous
polymorphisms rs2228246 PLCG1 and rs35211496 TNFRSF11A and the
non encoding SNP rs12746200, which could be involved in PLA2G4A
regulation and urticaria induced by multiple NSAIDs.
